Arlington, Tennessee-based MicroPort Orthopedics Inc. is changing the way it advances patient care by investing in new technologies and partnerships to focus on an Episode of Care approach.
The company’s Episode of Care approach will “enhance operational efficiency and patient satisfaction throughout the 90 days both before and after surgery.” To help improve patient engagement and evaluate patient outcomes, MicroPort Orthopedics has partnered with PatientIQ.
PatientIQ is a cloud-based platform which joins together patient engagement technology with advanced analytics. PatientIQ has more than 1,600 online education models that can be “tailored to a procedure or diagnosis.” The company also provides patient outcomes surveys and automates data collection.
MicroPort Orthopedics has also partnered with board certified orthopedic surgeon Aaron Salyapongse, M.D. to create a virtual joint class series. Dr. Salyapongse has extensive training in diagnosing and treating hip and knee disorders.
The virtual joint class series digitally delivers educational content that is designed to be interactive via its “blackboard style format.” The content includes a variety of topics including surgical preparation and post-op pain management. It also, according to the press release, “preemptively address[es] many of the common causes for patient adverse events and readmissions.”
MicroPort Orthopedics President Benny Hagag told OTW, “There are four things that fundamentally set our business apart from the competition. First, our approach to doing business as a company is to think globally, act locally with focus, speed, and impact. Second, to win in ortho moving forward, technology must lead the way. We are evolving our business structure to ensure technology is at the foundation of all that we do.”
Hagag continued, “Third, our core strategic business segments (knees, hips, ASCs [ambulatory surgery centers]) are all differentiated. Knee, we are the first and the leader in Medial Pivot philosophy. Hips, our tissue-sparing approaches via our proprietary portal provide real clinical benefits to the patients while giving the surgeons their choice in terms of approaches. ASCs, our PATHWAYS Program provides personalized tools to enable simplified and profitable Total Joint Replacement in the ASC setting throughout the Episode of Care.”
Hagag concluded, “Finally, our parent-company (MicroPort Scientific) being headquartered in Shanghai, China, provides us a unique strategic advantage in terms of access to the Chinese market.”
Established in 2014, MicroPort Orthopedics develops, manufactures, and markets orthopedic hip and knee implants. Surgeons in more than 70 countries use its hip and knee products. Its knee products include primary total knee systems, revision total knee systems, and personalized solutions. Its hip products include acetabular hip systems, femoral stems, resurfacing systems, and tissue sparing surgical approaches.
